Literature DB >> 24310987

The value of vaginal packing in pelvic floor surgery: a randomised double-blind study.

G Thiagamoorthy1, A Khalil, L Cardozo, S Srikrishna, G Leslie, D Robinson.   

Abstract

INTRODUCTION AND HYPOTHESIS: The objective of this study was to evaluate the effect of vaginal packing following pelvic floor surgery with regard to post-operative pain, bleeding and infection. This was a double-blind randomised study of women undergoing vaginal hysterectomy and/or pelvic floor repair at a tertiary urogynaecology unit.
METHODS: The primary outcome of day 1 post-operative pain was assessed using the short-form McGill Pain score. Secondary outcomes were haematological and infective morbidity, evaluated using changes in full blood count, and cultures of midstream urine and high vaginal swabs. A transvaginal ultrasound scan to exclude pelvic haematoma was performed at 6 weeks in all women who underwent vaginal hysterectomy with or without a pelvic floor repair.
RESULTS: In total, 190 women were recruited: mean age 58.3 years (27-91 years), mean body mass index 27.4 kg/m(2) and median parity 3. Women were randomised into the 'pack' (n = 86) and 'no pack' (n = 87) arms with no demographic differences between the groups. No statistically significant differences in the post-operative pain scores or secondary outcome measures were demonstrated. Incidence of haematoma formation (14.8 % no pack, 7.3 % pack, p = 0.204) was not statistically significant. There were three clinically significant complications in the no pack group and none in the pack group.
CONCLUSIONS: This is the first study to examine pain in association with post-operative vaginal packing. There is no evidence to suggest that packing increases pain scores or post-operative morbidity. A trend towards increased haematoma and significant complications was seen in the no pack group. As vaginal packing does no harm and may be of some benefit it may be argued that packing should be recommended as routine clinical practice.

Entities:  

Mesh:

Year:  2013        PMID: 24310987     DOI: 10.1007/s00192-013-2264-y

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  25 in total

1.  Vaginal cleansing and postoperative infectious morbidity in vaginal hysterectomy. A register study from the Swedish National Register for Gynecological Surgery.

Authors:  Preben Kjølhede; Shefqet Halili; Mats Löfgren
Journal:  Acta Obstet Gynecol Scand       Date:  2010-11-26       Impact factor: 3.636

2.  Comparative clinical and pharmacokinetic aspects of cefotetan versus cefoxitin plus metronidazole in vaginal hysterectomy.

Authors:  K Engel; W Schmidt; H G Sonntag; F Kees
Journal:  J Chemother       Date:  1989-07       Impact factor: 1.714

3.  Prophylactic mezlocillin in vaginal hysterectomy: a prospective, randomized study.

Authors:  R Conturso; L Radaelli; P Turtulici; G Alegente; F De Lalla
Journal:  J Chemother       Date:  1989-07       Impact factor: 1.714

4.  Vaginal hysterectomy: cefuroxime, metronidazole or both?

Authors:  F M Kauer; J Wijma; W L Manson
Journal:  Pharm Weekbl Sci       Date:  1990-12-14

5.  Comparison of abdominal and vaginal hysterectomy. Study of complications.

Authors:  D Kalogirou; G Antoniou; P Karakitsos; C Zioris; C Salampasis
Journal:  Clin Exp Obstet Gynecol       Date:  1996       Impact factor: 0.146

6.  Hysterectomy: a historical perspective.

Authors:  C Sutton
Journal:  Baillieres Clin Obstet Gynaecol       Date:  1997-03

Review 7.  Extensive gynecologic surgical procedures upon patients more than 75 years of age.

Authors:  J Schneider; R Benito
Journal:  Surg Gynecol Obstet       Date:  1988-12

8.  Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence.

Authors:  A L Olsen; V J Smith; J O Bergstrom; J C Colling; A L Clark
Journal:  Obstet Gynecol       Date:  1997-04       Impact factor: 7.661

9.  Effects of nonabsorbable packing in middle meatus after sinus surgery.

Authors:  Vegard Bugten; Ståle Nordgård; Eirik Skogvoll; Sverre Steinsvåg
Journal:  Laryngoscope       Date:  2006-01       Impact factor: 3.325

10.  Conservative versus surgical management of prolapse: what dictates patient choice?

Authors:  Dharmesh S Kapoor; Ranee Thakar; Abdul H Sultan; Reeba Oliver
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-06-19
View more
  6 in total

Review 1.  Managing novel orally administered anticoagulants in patients undergoing urogynaecological surgery.

Authors:  Claire M McCarthy; Orfhlaith E O'Sullivan; Barry A O'Reilly
Journal:  Int Urogynecol J       Date:  2015-12-30       Impact factor: 2.894

2.  Interventions to reduce morbidity from vault hematoma following vaginal hysterectomy: a systematic review and meta-analysis.

Authors:  Suneetha Rachaneni; Anupreet Dua
Journal:  Int Urogynecol J       Date:  2018-11-29       Impact factor: 2.894

3.  Anesthetics' role in postoperative urinary retention after pelvic organ prolapse surgery with concomitant midurethral slings: a randomized clinical trial.

Authors:  Alexandriah Alas; Laura Martin; Hemikaa Devakumar; Lawrence Frank; Sneha Vaish; Neeraja Chandrasekaran; G Willy Davila; Eric Hurtado
Journal:  Int Urogynecol J       Date:  2019-03-23       Impact factor: 2.894

4.  A UK questionnaire survey of current techniques used to perform pelvic organ prolapse repair.

Authors:  Emily Fairclough; Jenny Myers; Anthony Ross Broadhurst Smith; Suzanne Breeman; Fiona Reid
Journal:  Int Urogynecol J       Date:  2017-02-01       Impact factor: 2.894

5.  Forgotten gauze piece will not be forgiven always.

Authors:  S Rajaian; M Pragatheeswarane; K Krishnamurthy; L Murugasen
Journal:  J Postgrad Med       Date:  2019 Jul-Sep       Impact factor: 1.476

6.  A systematic review of outcome and outcome-measure reporting in randomised trials evaluating surgical interventions for anterior-compartment vaginal prolapse: a call to action to develop a core outcome set.

Authors:  Constantin M Durnea; Vasilios Pergialiotis; James M N Duffy; Lina Bergstrom; Abdullatif Elfituri; Stergios K Doumouchtsis
Journal:  Int Urogynecol J       Date:  2018-10-22       Impact factor: 2.894

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.